<DOC>
	<DOCNO>NCT01223014</DOCNO>
	<brief_summary>Phase I study evaluate excretion radioactivity , metabolic profile , pharmacokinetics , safety tolerability follow single oral administration [ 14C ] AZD2423 healthy male volunteer age 50 65 year ( inclusive ) .The purpose study investigate quickly AZD 2423 break product excrete analyse blood , faeces urine sample collect study .</brief_summary>
	<brief_title>Study Evaluating Absorption , Distribution , Metabolism Excretion ( ADME ) Single Dose 14C AZD2423 Volunteers</brief_title>
	<detailed_description />
	<criteria>Have body mass index ( BMI ) ≥18 ≤30 kg/m2 weight ≥50 kg ≤100 kg Regular daily bowel movement ( ie , production least 1 stool per day ) Provision sign date , write informed consent prior study specific procedure Healthy volunteer expose radiation level background ( eg , X ray examination ) &gt; 5 mSv last year , &gt; 10 mSv last 5 year cumulative total &gt; 1 mSv per year life Participation prior radiolabelled study within 12 month screen visit ( Visit 1 ) History alcohol abuse excessive intake alcohol define regular intake 15 unit alcohol week . ( unit = 1 glass wine ( 125 mL ) = 1 measure spirit = ½ pint beer )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Radioactive</keyword>
	<keyword>ADME</keyword>
	<keyword>Neuropathic pain</keyword>
</DOC>